Top 34 medical and healthcare startups in Netherlands
Nov 16, 2025
|
Like
22
1
Funding: $1.2B
Founded is a clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases
Founded is a clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases
2
Funding: $855.7M
uniQure is delivering on the promise of gene therapy, single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease modifying therapies to patients with severe disorders. We believe our multiple partnerships and the regulatory approval of our lead product Glybera in the European Union for a subset of patients with LPLD provides validation for our approach.
uniQure is delivering on the promise of gene therapy, single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease modifying therapies to patients with severe disorders. We believe our multiple partnerships and the regulatory approval of our lead product Glybera in the European Union for a subset of patients with LPLD provides validation for our approach.
3
Funding: €160M
VectorY Therapeutics develops gene therapies against amyotrophic lateral sclerosis (ALS) and Alzhiemer’s disease.
VectorY Therapeutics develops gene therapies against amyotrophic lateral sclerosis (ALS) and Alzhiemer’s disease.
4
Funding: €157M
Azafaros B.V. aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Azafaros B.V. aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
5
Funding: $149.4M
NorthSea Therapeutics is a biotech company developing first-in class, oral, structurally-engineered lipid therapeutics targeting metabolic, inflammatory and fibrotic diseases. The SEFA technology has generated pipeline candidates with a broad array of inter- and independent biological effects, improving dyslipidemia, insulin resistance, hepatic inflammation and fibrosis in diverse models.
NorthSea Therapeutics is a biotech company developing first-in class, oral, structurally-engineered lipid therapeutics targeting metabolic, inflammatory and fibrotic diseases. The SEFA technology has generated pipeline candidates with a broad array of inter- and independent biological effects, improving dyslipidemia, insulin resistance, hepatic inflammation and fibrosis in diverse models.
6
Funding: €96.1M
Micreos is a developer of phage technology for targeted control of bacteria. Micreos’ big idea is to use enzymes made by bacteriophages to selectively take out bacteria without drug resistance.
Micreos is a developer of phage technology for targeted control of bacteria. Micreos’ big idea is to use enzymes made by bacteriophages to selectively take out bacteria without drug resistance.
7
Funding: $102.9M
Lava Therapeutics has developed a proprietary platform focused on developing next generation T cell engaging bispecific antibodies.
Lava Therapeutics has developed a proprietary platform focused on developing next generation T cell engaging bispecific antibodies.
8
Funding: $64.4M
Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.
Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.
9
Funding: $54.4M
Onera advances sleep medicine by creating breakthrough diagnostic solutions that help people who struggle with sleep-related ailments.
Onera advances sleep medicine by creating breakthrough diagnostic solutions that help people who struggle with sleep-related ailments.
10
Funding: €37.6M
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
11
Funding: €32M
Vitestro transform patient care with autonomous blood drawing technology. The company's device utilizes ultrasound-guided, AI-based 3D reconstruction with robotic needle insertion to collect a user's blood.
Vitestro transform patient care with autonomous blood drawing technology. The company's device utilizes ultrasound-guided, AI-based 3D reconstruction with robotic needle insertion to collect a user's blood.
12
Funding: €50K
Xilloc Medical aims to provide patient specific implants to reconstruct parts of the human’s skeleton.
Xilloc Medical aims to provide patient specific implants to reconstruct parts of the human’s skeleton.
13
Funding: $16.5M
SkinVision is a mobile app that allows you to understand your risk factors for skin cancer and keep track of your moles.
SkinVision is a mobile app that allows you to understand your risk factors for skin cancer and keep track of your moles.
14
Funding: $17.1M
Landcent is accelerating the fight against infectious diseases of poverty through affordable, scalable and safe technologies.
Landcent is accelerating the fight against infectious diseases of poverty through affordable, scalable and safe technologies.
15
Funding: €14M
Siilo is a secure and compliant messaging and collaboration for healthcare teams.
Siilo is a secure and compliant messaging and collaboration for healthcare teams.
16
Funding: $13.4M
An online fitness platform for consumers & professionals in the health industry
An online fitness platform for consumers & professionals in the health industry
17
Funding: $2M
NovioSense develops tear glucose measurement device. Their vision is to free diabetics from the painful finger prick and throughout this leverage for their shareholders the significant market potential that such a non-invasive glucose monitor could achieve.
NovioSense develops tear glucose measurement device. Their vision is to free diabetics from the painful finger prick and throughout this leverage for their shareholders the significant market potential that such a non-invasive glucose monitor could achieve.
18
LivAssured develops NightWatch - the armband that notifies caregivers remotely of nightly epileptic seizures.
19
Funding: €8.8M
QDI systems is a start-up company that develops imaging devices based on quantum dots for medical X-ray applications.
QDI systems is a start-up company that develops imaging devices based on quantum dots for medical X-ray applications.
20
Funding: €250K
ARTPred is developing technology intended to predict the odds of failure of an embryo to implant in the uterus during in-vitro fertilization procedures. The platform is based on biomarker profiles of the urogenital microbiome.
ARTPred is developing technology intended to predict the odds of failure of an embryo to implant in the uterus during in-vitro fertilization procedures. The platform is based on biomarker profiles of the urogenital microbiome.
21
Funding: €7.1M
Quantib BV is a medical technology company that develops innovative software in the field of quantitative MRI and CT image analysis.
Quantib BV is a medical technology company that develops innovative software in the field of quantitative MRI and CT image analysis.
22
Funding: $7.4M
Lapsi Health is a Medical Technology company developing Digital Biomarkers from medical sound analytics. In particular it develops digital stethoscope for detecting childhood asthma.
Lapsi Health is a Medical Technology company developing Digital Biomarkers from medical sound analytics. In particular it develops digital stethoscope for detecting childhood asthma.
23
Funding: $4.1M
Women's health clinics specialised in fast diagnostics, treatments, surgery and outpatient services for and by women. All supported by our SHE. telehealth app for 24/7 care support
Women's health clinics specialised in fast diagnostics, treatments, surgery and outpatient services for and by women. All supported by our SHE. telehealth app for 24/7 care support
24
Funding: €2.3M
Detact Diagnostics developed portable test that can detect COVID-19 within 30 seconds.
Detact Diagnostics developed portable test that can detect COVID-19 within 30 seconds.
25
Funding: €1M
Skinive's goal is to provide personalized advice and prevent dangerous skin diseases among people.
Skinive's goal is to provide personalized advice and prevent dangerous skin diseases among people.
26
Funding: $1M
Reducept fights chronic pain with Virtual Reality. They have succeeded in developing a program that trains your brain to handle pain.
Reducept fights chronic pain with Virtual Reality. They have succeeded in developing a program that trains your brain to handle pain.
27
Funding: $366.2K
BeSure Online: AI-based digital health platform for cardiovascular disease prevention; Precise COVID19: remote #COVID19 patients monitoring
BeSure Online: AI-based digital health platform for cardiovascular disease prevention; Precise COVID19: remote #COVID19 patients monitoring
28
Funding: $100k
Using digital phenotyping to improve diagnosis and treatment. Clinicians and Patients are always connected through our AI based full stack mental health platform.
Using digital phenotyping to improve diagnosis and treatment. Clinicians and Patients are always connected through our AI based full stack mental health platform.
29
Glycostem is a clinical-stage company, harvesting the power of allogeneic cells like Natural Killer (NK) cells or antigen presenting cell in the field of cellular cancer immunotherapy.
30
AudioFysio focuses on audio exercise programs that are developed for back pain and back exercise.
31
SyncVR Medical aims to improve healthcare with extended reality (XR) (VR/AR) through the largest XR healthcare platform in Europe, offering a library of medical XR software applications. Such as applications to decrease pain, anxiety, and medication, or to train medical professionals through XR training simulations.
32
SpaceBorn United is a research/ bio-tech company that researches and enables the conditions for diferent stages of human reproduction in space. After validation missions with animal models, eventually also human babies will be conceived in space, for the first time in history. Enabled by our research roadmap and our space missions program.
33
Traverse Health is a pioneering company at the intersection of healthcare data and artificial intelligence. We specialize in organizing and analyzing real-world data sourced from Electronic Health Records. Our insights empower pharmaceutical and biotech companies, healthcare providers, and policymakers to enhance patient outcomes. What sets us apart is our exclusive access to crucial data on specific patient populations and diseases, which are otherwise unavailable in the market.
34
Gladskin is a Micreos brand,they provide solutions on a deep and thorough understanding of the problems of our customers.
★
See also:
